MLchartDataset catalogue

Tukysa

Term · Oncology and biomedicine · MLC-T-ONC-008952

A drug used with other drugs to treat adults with certain types of HER2-positive breast cancer or certain types of HER2-positive colorectal cancer that do not have a mutation (change) in the RAS gene. It is also being studied in the treatment of other types of cancer. Tukysa blocks a protein called HER2, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called tucatinib.

Table 1. Record
IdentifierMLC-T-ONC-008952
FieldOncology and biomedicine
Synonymstucatinib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008952",
  "term": "Tukysa",
  "field": "Oncology and biomedicine",
  "definition": "A drug used with other drugs to treat adults with certain types of HER2-positive breast cancer or certain types of HER2-positive colorectal cancer that do not have a mutation (change) in the RAS gene. It is also being studied in the treatment of other types of cancer. Tukysa blocks a protein called HER2, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called tucatinib.",
  "synonyms": [
    "tucatinib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tukysa/"
}

Record 16,808 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.